Outlook Therapeutics, Inc.

Healthcare

NASDAQ:OTLK · NASDAQ Capital Market

Market Cap $67.88M Beta 0.98 P/E (TTM) -2.1

$1.58 -5.76%

-$0.10 today

52W Low $0.16High $3.39

Vol 19.76M · Avg 17.46M

EPS (TTM) -$0.74Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-5.95%

Period High

$2.97

Period Low

$0.20

Latest

$1.58

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Century Therapeutics, Inc.

NASDAQ:IPSC

$197.80M

Equillium, Inc.

NASDAQ:EQ

$107.81M

OS Therapies Incorporated

AMEX:OSTX

$81.73M

Cue Biopharma, Inc.

NASDAQ:CUE

$71.06M

Spruce Biosciences, Inc.

NASDAQ:SPRB

$70.29M

NRx Pharmaceuticals, Inc.

NASDAQ:NRXP

$69.75M

Coeptis Therapeutics, Inc.

NASDAQ:COEP

$55.98M

Werewolf Therapeutics, Inc.

HOWL

$17.12M

Medicus Pharma Ltd. Common Stock

MDCX

$9.70M

IO Biotech, Inc.

IOBT

$885,690.00

What is the latest OTLK filing?

The latest filing shown is 8-K dated Jun 16, 2026.

How many recent filings does OTLK have?

Intrinsic Alpha currently shows 20 recent filings for OTLK.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.